Patent · US Active

Compound and methods for its production

US9090657B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignee

NEUROVIVE PHARMACEUTICAL AB · SE

Inventors

Matthew Alan Gregory · Bourn, GB
Steven Moss · Balsham, GB
Barrie Wilkinson · Cambridge, GB

Key dates

Filing date	Mar 29, 2012
Grant date	Jul 28, 2015
Priority date	—
Expiry date	Jul 7, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K5/0808
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is provided inter alia a compound of formula (I):for use in treatment of viral infection or as an immunosuppressant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.